The above results indicate that patients with increased serum occludin have a high risk of HT, regardless of non-reperfusion therapy or reperfusion therapy, suggesting that it may be a sensitive marker for prediction of intracranial hemorrhagic transformation. This evidence concerns the gene OCLN and hematocrit.